Adaptable alginate-based microfibers for 3D in vitro cultures of cancer cells: an anticancer drug testing model Abstract

Main Article Content

Jelena Petrović
Elżbieta Pańczyszyn
https://orcid.org/0000-0003-1948-0916
Marco Corazzari
Ivana Banićević
Milena Milivojević
Luka Bojić
https://orcid.org/0000-0002-1462-4557
Milena Stevanović
https://orcid.org/0000-0003-4286-7334
Miodrag Dragoj
https://orcid.org/0000-0001-6214-9220
Milica Pešić
https://orcid.org/0000-0002-9045-8239
Radmila Janković
https://orcid.org/0000-0001-5733-9505
Bojana Obradović
https://orcid.org/0000-0002-7276-0442
Jasmina Stojkovska
https://orcid.org/0000-0002-6732-3037

Abstract

The slow advance in anticancer drug development can be attributed to the limitations of conventional models, predominantly monolayer cell (2D) cultures and animal models, which inadequately recapitulate the complex nature of human malignant tumors. Three-dimensional (3D) in vitro models are invaluable tools in drug screening; however, creating a universal model for all cancer types poses challenges due to the diverse nature of cancers. The aim of this work was to develop a single, versatile model using alginate microfibers to accommodate cultivation of various cancer cells.

Article Details

How to Cite
[1]
J. . Petrović, “Adaptable alginate-based microfibers for 3D in vitro cultures of cancer cells: an anticancer drug testing model: Abstract”, Hem Ind, vol. 78, no. 1S, p. 21, Mar. 2024, Accessed: Nov. 25, 2024. [Online]. Available: https://www.ache-pub.org.rs/index.php/HemInd/article/view/1264
Section
Cancer research

How to Cite

[1]
J. . Petrović, “Adaptable alginate-based microfibers for 3D in vitro cultures of cancer cells: an anticancer drug testing model: Abstract”, Hem Ind, vol. 78, no. 1S, p. 21, Mar. 2024, Accessed: Nov. 25, 2024. [Online]. Available: https://www.ache-pub.org.rs/index.php/HemInd/article/view/1264

Funding data

References

Panczyszyn, E., Saverio, V., Monzani, R., Gagliardi, M., Petrovic, J., Stojkovska, J., Collavin, L., Corazzari, M. FSP1 is a predictive biomarker of osteosarcoma cells’ susceptibility to ferroptotic cell death and a potential therapeutic target. Cell Death Discov. 2024; 10: 87. https://doi.org/10.1038/s41420-024-01854-2

Most read articles by the same author(s)

1 2 3 > >>